Suzan K. DelbeneSell
BIOA Common Stock · Transaction Jun 9, 2016 · Filed Jul 13, 2016 · Amount pending receipt enrichment
NASDAQ NMS - GLOBAL MARKET · BIOA
-0.11% · -$0.0100 · Vol 661.6K
Market closed · last close 4:00 PM ET · price as of 19:07:43 ET
BIOAGE Labs Inc
Pharmaceuticals
$9.47
Veridion Score
BETAHIGH CONF · 6/6 factorsMon Aug 24 · market closed · Markets closed · resumes Tue 9:30 ET · BIOA
MethodologyBIOA
BIOAGE Labs Inc
Mon Aug 24 · market closed · Markets closed · resumes Tue 9:30 ET
SELL BIAS
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
34/ 100
Veridion Score
SELL BIAS · HIGH confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Mon Aug 24 · market closed · Markets closed · resumes Tue 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is BIOA moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About BIOAGE Labs Inc
PHARMACEUTICAL PREPARATIONSListed since
2024
Employees
62
Country
US
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$9.57
Day high
$9.65
Day low
$9.16
Previous close
$9.48
52W high
$25.10
-62.27% from high
52W low
$4.51
24% of range
Market cap
$435.1M
EPS
$-2.2600
Beta
1.61
Shares out
45.9M
Volume
661.6K
0.60× rel vol
Avg volume
1.1M
VWAP
$9.35
Price history computed in-house
1W
-9.46%
1M
-56.50%
3M
-44.13%
1Y
+109.98%
YTD
-28.42%
SMA 50 $18.49 · below
SMA 200 $16.84 · below
52W position 24%
BIOA overview
Related filings and maps
Public disclosures
Congress activity in BIOA
Official filing ↗
BIOA Common Stock · Transaction Oct 10, 2014 · Filed Nov 20, 2014 · Amount pending receipt enrichment
BIOA Common Stock · Transaction Oct 9, 2014 · Filed Nov 20, 2014 · Amount pending receipt enrichment
BIOA Common Stock · Transaction Jul 24, 2014 · Filed Aug 17, 2014 · Amount pending receipt enrichment
Federal contracts
BIOA contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BIOA in this window.
Lobbying spend
BIOA lobbying filings, year to date.
Registered lobbying filings matched to BIOAGE Labs Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BIOA in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for BIOA.
Options
Sovereign unlock shows live options positioning for BIOA.